Within recent years, the United States has experienced phenomenal growth in the provision of both formal (e.g., by paid agencies and professional personnel) and informal (e.g., by family members or friends) long term home care services for persons with mental and physical disabilities (Kapp,...
This scoping review was undertaken to systematically map all national policies for healthy ageing in mainland China over the last five-year planning cycle, from 2016 to 2020, with the aim of characterising the national policies for healthy ageing and identifying the policy gaps from a health ...
Agencies providing services for families experiencing homelessness face challenges, particularly with diminishing resources driven and prioritized by policy mandates. To understand the impact of policies related to homeless families, we conducted a qualitative, exploratory study including the chief executive of...
In this chapter we discuss the research related to family care policies and programs. Specifically, we discuss the evidence related to employee and organizational consequences of family care practices. We also explain how these consequences occur using w
Hepatitis B virus (HBV) infection is a serious public health concern, with over 350 million cases and more than 1.5 million new cases annually [1]. This infection has a greater number of deaths than any other form of viral hepatitis and causes severe illness, accounting for about 900,000 ...
Health technology assessment (HTA) agencies worldwide are thus exploring whether real-world data (RWD) may provide alternative sources of data on effectiveness of interventions. Presently, an overview of HTA agencies' policies for RWD use in relative effectiveness assessments (REA) is lacking....
Rare disease (RD) management and orphan drug development in India face various hurdles regarding the implementation and adoption of comprehensive policies, lack of dedicated regulatory frameworks, and absence of epidemiological data. Current rare disease
Rare disease (RD) management and orphan drug development in India face various hurdles regarding the implementation and adoption of comprehensive policies, lack of dedicated regulatory frameworks, and absence of epidemiological data. Current rare disease
health information. ARS NETWORK does not control or monitor the information or data you store on, or transmit through, the Services. We specifically disclaim any representation or warranty that the Services, as offered, comply with the federal Health Insurance Portability and Accountability Act (“...
HIAs are indeed recognized formally as important tools to consider adverse health impacts of changing environments in various developed countries both in Europe and North America [57], and are actively promoted by health agencies in Finland, New Zealand, Switzerland, Germany and the UK. The SDG ...